Mutant mice of milmi genotype are osteopetrotic and deficient in tissue mast cells due t o a defect in osteoclasts and mast cells. In an effort t o further understand the mechanisms behind why mi/mimouse-derived cultured mast cells (milmi-CMC) responded t o interleukin-3 (IL-3). but not t o the proliferative stimuli presented by fibroblasts, milmi-CMC and congenic normal (+I +) mouse-derived CMC (+I +-CMC), both of which expressed the phenotypic characteristics of immature mast cells, were cocultured with Swiss albinol3T3 fibroblasts in a medium containing IL-3. In the in vitro CMCIfibroblast coculture, milmi-CMC did not acquire the phenotypes of connective tissue-type mast cells (CTMC), while +I +-CMC did. In addition, attachment of milmi-CMC t o the fibroblasts was found t o be significantly lower than that of +I +-CMC. Because the interaction of c-kit product with its ligand (stem cell factor [SCq) is known t o play an important role not only in proliferation and differentiation of mast cells but also in attachment of CMC t o fibroblasts, the expression and function of c-kit were investigated in milmi-CMC and +I+-CMC. Recombinant rat SCF (rrSCF'@) induced a dose-dependent proliferation of + / +-CMC. Also,
chromosome 10, or the mi locus on chromosome 6 leads to a deficiency of mast cells or melanocytes in tissues of mice.I4 The products of two (W and SI) of these three loci have recently been identified:-" The W locus encodes the c-kit tyrosine kinase receptor,5T6 whereas the SI locus encodes the ligand for the c-kit product, which is variously designated as stem cell factor (SCF),7f8 mast cell growth factor? kit ligand,"J or steel factor." In contrast, the product of the mi locus is not fully characterized at this time.
In the previous study, we have shown that, despite mast cell deficiency in milmi mice, mast cells developed when spleen cells of milmi mice were cultured in the presence of T-cell-derived growth factors containing interleukin-3 (IL-3) rrSCFlW induced +/+-CMC t o acquire the phenotypes of CTMC in the medium containing IL-3. By contrast, rrSCFlW did not stimulate the proliferation of milmi-CMC nor induce a phenotypic change of the cells from immature mast cells t o mature, CTMC-like mast cells. lmmunoblotting with antiphosphotyrosine antibody showed that rrSCFlW induced considerable tyrosine phosphorylation of 145-t o 165-Kd protein, the product of c-kit, in +I +-CMC, whereas tyrosine phosphorylation of the protein was barely detectable in milmi-CMC. Northern blot and flow cytometry analyses showed that milmi-CMC expressed much less c-kit at both protein and message levels than +I +-CMC. Further, milmi-CMC were found t o differ from +I+-CMC in the expression of mouse mast cell protease-6 (MMCP-6) and MMCP-2 messenger RNA transcripts. These results suggest that the gene product of themi locus may be important in regulating the expression of gene products such as c-kit. and that mast cell deficiency of milmi mice appears t o be due, at least in part, t o impaired signaling through the c-kit receptor because of the low c-kit expression. o 1992 by The American Society of Hematology.
and IL-4. 4 The proliferative response of milmi mousederived cultured mast cells (milmi-CMC) to those growth factors was comparable with that of congenic normal (+ / +) mouse-derived CMC (+ 1 +-CMC). In contrast, when CMC were cocultured with NIHl3T3 fibroblasts, milmi-CMC could not be maintained in the absence of exogenous growth factors, while +I+-CMC showed a fibroblast-dependent growth. 4 Further, fibroblasts derived from the skin of milmi mice normally supported the proliferation of +I + -CMC. 4 These results suggested that the mast cell deficiency of milmi mice appeared to be due to the inability of milmi mast cells to respond to the proliferative stimuli presented by fibroblasts.
In addition, although practically all mast cells in the skin of +I + mice showed the phenotypes of connective tissuetype mast cells (CTMC): most of the mast cells in the skin of milmi mice appeared to have the phenotypes of immature or mucosal mast cell (MMC)-like mast cells, but not of mature CTMC. 4 Because differentiation of immature, MMC-like mast cells to CTMC-like mast cells occurs in the connective tissues of mice12J3 and rats,14 this step of differentiation appears to be impaired in milmi mice. 4 Levi-Schaffer et a1 reported that the phenotypic change from immature, MMC-like mast cells to CTMC-like mast cells could be reproduced in vitro by coculturing immature, MMC-like CMC with Swiss albino13T3 fibroblasts in the presence of IL-3.15 Because the proliferation of milmi-CMC was supported by IL-3, the in vitro CMCIfibroblast coculture system appeared to be useful for the investigation of the defective differentiation of mast cells in milmi mice.
In the present study, we found that the defect of milmi mast cell in acquisition of a CTMC-like phenotype could be reproduced in an in vitro fibroblast1CMC coculture system. When +I+-CMC, which showed the phenotypes of imma-
ture mast cells, were cocultured with fibroblasts in a medium containing IL-3, they acquired CTMC-like phenotypes. In contrast, milmi-CMC were maintained in the culture condition, but did not acquire the CTMC-like phenotype. Moreover, we noted that the attachment of milmi-CMC to the fibroblasts was significantly impaired. Tsai et a1 reported that SCF by itself could stimulate proliferation of CMC and also induce immature, MMC-like CMC to mature and acquire CTMC-like phenotypes. 16 In addition, we have recently found that the extracellular domain of c-kit receptor appears to be necessary for attachment of CMC to fibrob1a~ts.l~ These findings led us to further examine the effect of SCF on proliferation and differentiation of milmi-CMC, and also to investigate the expression and signaling of c-kit receptor in milmi-CMC. SCF was found to induce proliferation and differentiation of +I+-CMC, but it had little effect on proliferation and differentiation of milmi-CMC. The expression of c-kit receptor was significantly lower in milmi-CMC than in +I +-CMC. In addition, milmi-CMC differed from + 1 + -CMC in the expression of mouse mast cell protease messenger RNA ( " A) transcripts before and after coculture with fibroblasts. These findings suggest that SCF-mediated signaling is impaired, at least in part, by the low amount of expression of c-kit, and also raise the possibility that mi gene product may play an important role in the regulation of multiple gene expressions in mast cells.
MATERIALS AND METHODS
The original stock of C57BL/6-mi/+ (mi/+) mice was purchased from the Jackson Laboratory (Bar Harbor, ME), and the mice were maintained in the Department of Pathology, Osaka University Medical School. Female mi/+ mice were crossed with male mi/+ mice, and the resulting milmi mice were selected by their white coat color. To obtain CMC, mice of milmi genotype and their normal (+ / +) littermates were used at 2 to 3 weeks of age. Mice were killed by decapitation after ether anesthesia. Spleens were removed, and cell suspensions were prepared as described previo~sly.~~ The Swiss albino/3T3 fibroblast and WEHI-3 cell lines were obtained from the Japanese Cancer Research Resources Bank (Tokyo, Japan). These two cell lines were adapted to grow in a-minimal essential medium (a-MEM Flow Laboratories, Irvine, UK) containing 10% fetal calf serum (FCS; Hyclone, Logan, UT), 100 U/mL penicillin, and 100 pg/mL streptomycin.
Reagents. Recombinant rat SCFIW (rrSCFla) was a gift from Dr Krisztina M. Zsebo (Amgen Inc, Thousand Oaks, CA)? The preparation of the ACK2 rat monoclonal antibody (MoAb) and its specificity against the extracellular domain of the c-kit product have been described in detail.l8J9 The antiphosphotyrosine antibody is murine MoAb generated against phosphotyramine as the immunogenM and was generously supplied by Dr Brian Druker (Dana-Farber Cancer Institute, Boston, MA). The specificity of the antiphosphotyrosine MoAb was described previously?0 Chemically defined serum-free medium (ASF-102) was purchased from Ajinomoto (Tokyo, Japan); it contains human transferrin, insulin, and bovine serum albumin.
Establishment of CMC. WEHI-3 is a mouse myelomonocytic leukemia cell line that constitutively produces IL3.21 WEHI-3-conditioned medium was prepared as described previously.21 WEHI-3 cells (2 x l@/mL) were incubated for 5 days in a-MEM containing 10% FCS. The conditioned medium was centrifuged, Mice and cells. filtered through a 0.22-pm filter (Millipore Corp, Bedford, MA), and stored at -80°C.
Culture flasks (Nunc, Roskilde, Denmark) containing 4 x lo7 spleen cells and 5 mL a-MEM supplemented with 10% FCS and 50% WEHI-3-conditioned medium were incubated at 37°C in a humidified atmosphere of 5% COz in air. 4 Half of the medium was replaced every 7 days, and more than 95% of cells were CMC at 4 weeks after the initiation of the c u l t~r e .~J~ Swiss albino/3T3 fibroblasts (1 x 104 cells) were suspended in 2 mL a-MEM supplemented with 10% FCS, and seeded in 35-mm culture dishes. The culture medium was aspirated and replaced with 2 mL of fresh medium every 3 days. After 7 days, the fibroblasts formed a confluent monolayer in each dish containing 0.5 to 1.0 x 106 fibroblasts. The medium of the confluent culture was aspirated, and 5 X 105 CMC suspended in 2 mL a-MEM supplemented with 10% FCS was added with or without WEHI-hnditioned medium (50% vol/vol). The medium of CMC/fibroblast multure was changed every 2 days by two different methods. First, it was changed according to the original method described by Levi-Schaffer et
The medium was aspirated, and the fibroblast layer was washed once with 2 mL of fresh medium to remove nonattaching CMC. The aspirated medium and the medium used for washing were discarded. Second, the aspirated medium and the medium used for washing were centrifuged at 12% for 5 minutes and resuspended in 2 mL of fresh medium, and then returned to the coculture. CMC that did not attach to fibroblasts were not lost in this method.
At various times after the initiation of multure, the numbers of mast cells were estimated from the total hemocytometer count and the proportion of mast cells. The proportion of mast cells was determined by staining the cytospin preparations (Shandom Southern, Elliott, IL) with alcian blue.
Profijeration assay of CMC. To quantitate the proliferation of CMC, we used 3-(4, 5-dimethythiazol-2-y1)-2, 5-diphenyl tetrazolium bromide ( M V , Sigma Chemical, St Louis, MO) rapid colorimetric assay as described previously, but with a minor modification?z.u Briefly, triplicate aliquots of CMC (3 x 104 cells suspended in 100 pL of a-MEM containing 10% FCS and rrSCFlM) were cultured in 96-well flat-bottom microtiter plates for 72 hours at 37°C. For the MTT assay, MTT (10 pL of a 5 mg/mL solution of MTT in phosphate-buffered saline [PBS] ) was added to all wells, and plates were incubated for 4 hours. Acid isopropanol (100 pL of 0.04N HCI in isopropanol) was added to all wells, and mixed thoroughly to dissolve the dark blue crystals. The optical density (OD) was then measured on a Microeliza plate reader (Corona Electric, Ibaragi, Japan) with a test wavelength of 550 nm and a reference wavelength of 630 nm. This assay was found to be more reproducible and reliable than 3H-thymidine incorporation or cell enumeration, as described previously~o~x although equivalent results were obtained with all three assays.
CMC were cocultured with Swiss albino/3T3 fibroblasts as described above, or maintained in culture medium supplemented with rrSCFIW (100 ng/mL) and WEHI-3-conditioned medium (50% vol/vol) as a source of IL-3. In the in vitro culture with IL-3 and rrSCFIM, half of the culture medium was replaced twice a week. At various times after the initiation of the culture, the number of mast cells was estimated from the hemocytometer count, and the cytospin preparations were k e d in Carnoy's solution for staining with alcian blue and safranin. Staining methods for alcian blue and safranin have been described.lLZ Alcian blue stains all types of mast cells such as CTMC and immature mast cells, whereas safranin stains only CTMC.15326
In addition, CMC or a CMC/fibroblast coculture were centrifuged, and 2% perchloric acid was added to the pellet. CMC dissolved in 2% perchloric acid were applied to a column of high with Swiss albino/3T3 fibroblasts as described above. At various times after the coculture of +/+-CMC and milmi-CMC with fibroblasts in the presence or absence of WEHI-3-conditioned medium, culture dishes were washed four times with a-MEM to remove nonattaching CMC as described.17 Fibroblasts and CMC attaching to the fibroblasts were harvested after the trypsin treatment and fixed with Camoy's solution. Cytocentrifuge specimens were first stained with alcian blue and then with nuclear fast red. The number of remaining mast cells per fibroblast was calculated as described. 17 Exponentially growing CMC were washed three times with a-MEM, and incubated in serum-free ASF-102 medium for 6 hours at 37°C to factor-deprive the cells. The cells (lo7 cells suspended in 1 mL of ASF-102 medium) were then exposed to 100 ng/mL of rrSCFlffl at 37°C for 15 minutes. After stimulation, cells were washed with cold PBS and lysed in 100 pL of lysis buffer containing protease and phosphatase inhibitors, as described previously." Insoluble material was removed by centrifugation at 10,00$ for 15 minutes at 4°C. The cell lysates were frozen at -80°C until use.
Cell lysates (150 Kg) were mixed 2 1 with 3x sodium dodecyl sulfate (SDS) sample buffer with 2-mercaptoethanol (Sigma), heated at 100°C for 5 minutes, and subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) with 7.5% polyacrylamide. After electrophoresis, proteins were electrophoretically transferred from the gel onto a polyvinylidene difluoride membrane (Immobilon; Millipore Corp, Bedford were size-fractionated by electrophoresis through 1.0% agarose gels containing 2.2 nmol/L formaldehyde. Before transfer to nitrocellulose papers, the ethidium-stained gels were visualized under ultraviolet illumination to determine the position of the ribosomal RNA bands, and to verify that equal amounts of RNA had been loaded. The c-kit probe consisting of a 1.1-kb fragment was prepared in our laboratory, and encoded part of the extracellular domain (nucleotide number 1 to 1090) of c-kit. The full-length p-actin probe was kindly provided by Dr S. Sakiyama (Chiba Cancer Center Institute, Japan)?O and used to verify that an equal amount of mRNA was loaded in each lane. For detection of MMCP-6, MMCP-2, and MC-CPA mRNA transcripts, all of which are known as good markers for the analysis of mast cell phenotype~,3l-~~ sense and antisense oligonucleotide primers specific for the coding regions of those genes were Proportion of CMC attaching to fibroblasts.
Stimulation with rrSCFlM and cell lysis.
Gel electrophoresis and immunoblotting. . The numbers represent the nucleotide numbers on the complementary strands of each cDNA s e q~e n c e .~~,~L~~ Total cellular RNA (5 pg) from CMC of C57BL/6-+/+ mice was used as a template and the single-strand cDNA was synthesized with downstream antisense primers by reverse transcriptase (Takara Shuzou, Kyoto, Japan). cDNA was amplified in a 100 ILL reaction mixture by a Perkin-Elmer Cetus DNA thermal cycler (Norwalk, CT) using Taq DNA polymerase in 30 cycles of 1 minute of denaturation at 94"C, 2 minutes of annealing at 5YC, and 3 minutes of synthesis at 72"C.36 Polymerase chain reaction (PCR) products were examined on 1% agarose gel. For the analysis of DNA sequence, PCR products were gel purified, treated with T4 polynucleotide kinase, and then with the Klenow fragment of DNA polymerase I. The products were subcloned into the EcoRV site of Bluescript KS (Stratagene, La Jolla, CA). DNA sequencing reaction was performed by the method of Sanger et aP7 using [32P]-a-dCTP.
After prehybridization, the filters were hybridized with random 32P-labeled probes with specific activities of 1 to 5 x 108 cpm/pg in 10% dextran sulfate, 50% formamide, 4x standard saline citrate (SSC), 1 X Denhardt's solution, and 10 pg/mL salmon sperm DNA for 24 hours at 42°C. The filters were washed and autoradiographed at -70°C with two intensifying screens.
RESULTS

CMC
were prepared from spleens of either milmi mice or normal (+ 1 +) mice in a medium containing WEHI-3-conditioned medium as a source of IL-3. The proliferative response of milmi-CMC to IL-3 was comparable with that of +/+-CMC. To determine whether milmi-CMC acquired CTMClike phenotypes when cocultured with Swiss albinol3T3 fibroblasts in the presence of IL-3, we used two coculture systems. In the first, CMC that did not attach to fibroblasts were discarded at each medium change. In the in vitro CMCIfibroblast coculture system, the number of +I +-CMC was maintained for 4 weeks, but the number of milmi-CMC decreased to about 1% of that of +I+-CMC (Fig 1) . Because of the disappearance of milmi-CMC, it was impossible to determine whether milmi-CMC acquired the CTMC phenotypes on the fibroblast layer. In the second, we did not discard the culture media, but the media containing nonattaching CMC were collected and centrifuged, and then the cells recovered in the pellets were returned to the coculture. In this coculture system, the number of milmi-CMC was comparable to that of +/+-CMC 2 weeks after the initiation of the coculture. We therefore used our modified method to examine the phenotypic change of milmi-CMC.
Phenotypes of CMC were examined before and 2 weeks after the initiation of the coculture. Before the coculture, there was little difference in histamine content and the proportion of safranin-positive cells between milmi-CMC and +I+-CMC (histamine content of milmi-CMC and Coculiure of CMC with Swiss albino/3T3fibroblasts.
For Weeks after Co-culture Also, the proportion of safranin-positive cells was significantly lower in the former than in the latter (milmi, 0.2% -C 0.1%; +/+, 53.1% 2 11.2%).
Detection of MMCP-6, MMCP-2, and MC-CPA mRNA transcripts in +I+-CMC and milmi-CMC. In addition to histamine content and staining properties with alcian blue/ safranin, MMCP and MC-CPA have recently been reported to be good markers for defining the phcnotypes of mast cell^.^^'-^^ We therefore examined the transcription of MMCP-6, MMCP-2, and MC-CPA in +I+-CMC and milmi-CMC before and 2 weeks after coculture with fibroblasts (Fig 2) . The 1.1-kb mRNA transcripts for MMCP-6 werc detected in +/+-CMC and found to be increased after the coculture, whereas MMCP-6 mRNA was not detected in milmi-CMC before or even after the coculture (Fig 2) . By contrast, the 1.0-kb mRNA transcripts for MMCP-2 werc barely detectable in +/+-CMC, but easily detected in milmi-CMC, and coculturc of CMC with fibroblasts resulted in a slight increase of MMCP-2 transcripts in +/+-CMC, whereas a decrease of the transcripts was seen in the RNA samplc from milmi-CMC (Fig 2) . The 1.5-kb mRNA transcripts for MC-CPA were readily detcctable in all RNA samples of +/+-CMC and milmi-CMC with an equal level. No transcription of MMCP-6, MMCP-2, or MC-CPA was seen in RNA samples from Swiss albino/ 3T3 fibroblasts (Fig 2) .
When milmi-CMC were cocultured with fibroblasts even in the presence of IL-3, the number of milmi-CMC decreased after discarding nonattaching CMC, suggesting impaired attachment of the cells to fibroblasts. To directly show this impaired attachAttachment of CMC to fibroblasts. ment of milmi-CMC to fibroblasts, milmi-CMC and +/+-CMC were cocultured with Swiss albino/3T3 fibroblasts in the presence or absence of IL-3, and CMC attaching to the fibroblasts were determined at various times after the initiation of the coculture. The number of +I+-CMC attaching to fibroblasts reached a maximum at 3 to 6 hours, and gradually decreased thereafter (Fig 3) . The number of milmi-CMC attaching to fibroblasts was significantly lower than that of +/+-CMC (Fig 3) . The addition of IL-3 did not influence the number of attaching CMC in the coculture of cithcr + / +-CMC or milmi-CMC (Fig 3) .
Efect of SCF on proliferation and differentiation of CMC. We next cxamincd whcther SCF induced proliferation of CMC derived from milmi mice. CMC were cultured in the presence of 0 to 1,OOO ng1mL of rrSCF'@ for 3 days, followed by measurement of cell proliferation with the MTT colorimetric method. Although rrSCFI@ induced a dose-dependent proliferation of thc +/+-CMC over the range of 0.1 to 1, OOO ng/mL. rrSCF'@ had little effect on proliferation of milmi-CMC, even at a concentration of 1,OOO ng/mL (Fig 4) . The results of the M l T assay shown in 3H-thymidine incorporation (data not shown). Because 100 ng/mL of rrSCF1@ induced almost maximal proliferation of +I+-CMC, either +I+-CMC or milmi-CMC were cultured at this concentration of rrSCF1@ hereafter.
Further, to determine whether milmi-CMC acquired the CTMC-like phenotypes in response to rrSCF164 CMC were cultured for 6 weeks with or without SCF in a medium containing IL-3. At various times after the initiation of the culture in the presence of both SCF and IL-3, changes in phenotypes of CMC were examined. Four weeks after the initiation of the culture, the increase in the histamine 0. 5 content per lo6 mast cells was significantly lower in the culture of milmi-CMC than in that of +I+-CMC (Table 1) . Also, the proportion of safranin-positive cells was significantly lower in milmi-CMC than in +I+-CMC ( Table 1) . Tyrosine phosphorylation of cellular proteins in CMC afrer stimulation with rrSCF1&! To better understand the impaired effect of SCF on the proliferation and differentiation of milmi-CMC, we investigated the effect of SCF on tyrosine kinase activity in +I+-and milmi-CMC. CMC were removed from growth factors for 6 hours and then treated with 100 ng/mL of rrSCF1@ for 15 minutes. Changes in tyrosine phosphorylation were detected by immunoblotting with an MoAb specific for phosphotyrosine. Increased phosphotyrosine was observed in proteins, particularly at molecular weights 145 to 165 Kd, after stimulation of +I+-CMC with SCF (Fig 5) . Tyrosine phosphorylation of the protein was dependent on the dose of rrSCF,'@ and the degree of tyrosine phosphorylation roughly paralleled SCFinduced proliferation of +I+-CMC (data not shown). In contrast, tyrosine phosphorylation of the 145-to 165-Kd protein was barely observed in milmi-CMC after exposure to rrSCF'@ (Fig 5) .
We have previously shown that SCF induces tyrosine phosphorylation of c-kit product at a molecular weight of 145 to 165 Kd.38339 To determine whether the weak tyrosine phosphorylation of the 145-to 165-Kd protein in milmi-CMC after SCF treatment was due to low c-kit expression in milmi-CMC, we examined the expression of c-kit in +I+-CMC and milmi-CMC. Flow cytometry analysis using an MoAb ( A C E ) against the extracellular domain of c-kit product showed that expression of c-kit product on milmi-CMC was significantly lower (approximately 10%) than on + 1 +-CMC (Fig 6A) . Further, expression of c-kit gene was examined by means of Northern blot analysis. Consistently with the previous findings, c-kit transcripts gave a band of approximately 5.5 kb.40 The expression of c-kit mRNA transcripts in milmi-CMC was much lower (approximately 10%) than that in +I+-CMC (Fig 6B) . These results Low expression of e-kit in milmi-CMC. For indicated that milmi-CMC expressed a low amount of c-kit at both protein and message levels.
DISCUSSION
The product of c4it proto-oncogene is considered to be an indispensable molecule for stromal cell-dependent proliferation and differentiation of hematopoietic cells such as cells of erythroid and mast cell lineages as well as stem C~I I S . ' .~.~~ The product of c-kit is reported to be expressed on the surface of mast cells, and its ligand on stromal cells such as and the interaction of the c-kit receptor with its ligand is known to play an important role in mast cell growth and differentiation?" However, the expression and function of c-kit have not been studied in milmi mast cells in any detail.
We previously showed that milmi-CMC did not respond to the proliferative stimuli presented by fibroblasts that expressed c-kit ligand on their surfaq.4 Furthermore, in light of data on staining properties and histamine content, the present findings show that milmi-CMC do not acquire CTMC-like phenotypes, whereas +I+-CMC do acquire them during culture with fibroblasts or SCF. It 
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For personal use only. on October 23, 2017 . by guest www.bloodjournal.org From ture mast cell phenotypes. The transcription of MMCP-6 mRNA was increased by coculture of +I+-CMC with fibroblasts. These results, indicating the phenotypic alteration of +/+-CMC from immature mast cells to CTMClike mast cells, coincide with the data obtained from staining properties and histamine content. The expression of MMCP-6 and MMCP-2 mRNA transcripts in milmi-CMC is in marked contrast to that in +I+-CMC. milmi-CMC did not contain detectable levels of MMCP-6 mRNA transcripts, but expressed considerable amounts of MMCP-2 and MC-CPA mRNA transcripts. In addition, coculture of milmi-CMC with fibroblasts resulted in a slight decrease in MMCP-2 transcripts. The difference in the expression of MMCP-2 and MMCP-6 mRNA transcripts between +I +-CMC and milmi-CMC is interesting and suggests that some mechanism must exist to regulate MMCP expression in CMC. It is possible that mi may encode a gene product that is involved in regulating the expression of MMCP-2 and MMCP-6 genes. Also, it is possible that the gene product of mi locus may have some effect on the differentiation of mast cells so that milmi-CMC lie at a different stage of differentiation than +I +-CMC. Regarding MMCP-2 and MMCP-6 expression, milmi-CMC resemble MMC that are reported to express abundant mRNA transcript of MMCP-2 and little mRNA transcript of MMCP-6 in +/+-mice. However, milmi-CMC differ from MMC in the expression of MC-CPAMC-CPA is reported to be barely detectable in MMC, but it has been readily detectable in milmi-CMC. This is the first report regarding the expression pattern of MMCP and MC-CPA transcripts in milmi-CMC, and the pattern has not been described so far in any mast cell p~p u l a t i o n .~~-~~ Therefore it is rather difficult to use the expression pattern of MMCP and MC-CPA as a marker for analyzing the phenotypic change in milmi-CMC.
In this study, we first cocultured milmi-CMC with fibroblasts according to the method originally described by Levi-Schaffer et al,15 in which nonattaching CMC were discarded at each time of medium change. The number of milmi-CMC, but not of + 1 +-CMC, continued to decrease in the coculture system. In contrast, milmi-CMC were maintained by our modified coculture system in which nonattaching CMC were collected and returned to the coculture. Because the attachment of milmi-CMC to fibroblasts was significantly impaired, it was suggested that the expression of the molecule necessary for attachment to fibroblasts was impaired in milmi-CMC.
We recently investigated the role of the c-kit product in the attachment of CMC to fibroblasts in a CMCIfibroblast coculture system.17 The attachment to fibroblasts of WIW-CMC, which did not express the extracellular domain of the c-kit receptor, was significantly impaired. However, WIW-, W / W , or W/ W42-CMC, expressing the extracellular domain of the c-kit receptor, attached to fibroblasts at levels comparable to +/ +-CMC. Moreover, the attachment of +I+-CMC to fibroblasts was inhibited by the addition of ACK2 MoAb against the extracellular domain of the c-kit receptor. These results indicated that the extracellular domain of the c-kit receptor appeared to be necessary for attachment of CMC to fibrob1a~ts.l~ In the present study, we showed that the expression of c-kit receptor was significantly lower in milmi-CMC at both protein and message levels than in +I+-CMC. This finding suggests that the impaired attachment of milmi-CMC to fibroblasts is attributable to the low expression of the c-kit receptor in the cells.
The present study also showed that c-kit ligand, SCF, did not stimulate the proliferation of milmi-CMC, whereas it induced the proliferation of + 1 +-CMC in a dose-dependent manner. Because the growth of milmi-CMC was not supported by SCF alone but by IL-3 or the combination of IL-3 and SCF, we cultured milmi-CMC with both rrSCFlU and IL-3 to examine whether or not SCF was active in inducing phenotypic change in milmi-CMC. According to their safranin-staining properties and histamine content, milmi-CMC did not acquire CTMC-like phenotypes after treatment with SCF and IL-3, although +I+-CMC did. These results obtained by SCF were comparable with the results by the coculture with fibroblasts.
SCF has been shown to induce tyrosine phosphorylation of several proteins, including its receptor, in murine4244 and human cell line^.^*,^^ Immunoblotting with an MoAb against phosphotyrosine showed that the treatment of +I +-CMC with SCF resulted in a marked increase in tyrosine phosphorylation of 145-to 165-Kd protein, c-kit, and tyrosine phosphorylation of c-kit was found to be dose-dependent and correlated precisely with the rate of cell proliferation. However, SCF induced little tyrosine phosphorylation of the protein in milmi-CMC. The bare induction of tyrosine phosphorylation of c-kit by its ligand was found to be due to the low expression of c-kit protein in milmi-CMC. It is possible that tyrosine kinase activity of c-kit receptor may be weaker in milmi-CMC than in +I+-CMC because of the low expression of c-kit receptor, and that the low kinase activity of c-kit may contribute to the unresponsiveness of milmi-CMC to SCF stimulation. Although it is not fully known yet how c-kit expression is regulated, the present findings raise the possibility that the molecule defined by the mi locus may play some roles in regulating c-kit expression as well as MMCP and MC-CPA expression. Also, as discussed above, the low c-kit expression of milmi-CMC may be attributable to their different stage of differentiation. Additional information about the mechanisms responsible for the expression of c-kit, MMCP, and MC-CPA would be particularly helpful in understanding mast cell growth and function in milmi mice.
Recently, Dubreuil et a1 introduced c-fms gene, which encodes a tyrosine kinase receptor for macrophage colonystimulating factor, into CMC derived from W and mi mutant mice, and examined the survival of the CMC expressing c-fms receptor in an in vitro mast celllfibroblast coculture system.& They found that ectopic expression of c-fms complemented mutations at the W locus, but could not overcome the inability of milmi-CMC to survive in the culture system. These results raised the possibility that a common signal pathway might be used by c-kit and c-fmr; to promote cell proliferation, and also suggested either that the mi locus might define a common step in the c-kit and For personal use only. on October 23, 2017 . by guest www.bloodjournal.org From c-fms signal transduction pathways, or that mi might encode a parallel pathway necessary for c-kit and c-fms function. These findings seem to be at variance with our conclusions in the present study, but it is not sufficiently known yet if the impaired signaling of c-kit in milmi-CMC is because of low c-kit expression, a defect in one of downstream targets of c-kit receptor, or both of them. It would be of interest to examine whether ectopic expression of c-kit receptor by a heterologous promotor could complement the mi defect, and this examination could provide clues as to which molecules are critical for the impaired signaling of c-kit receptor. However, the phenotype of milmi mice is not completely identical to that of W mutant mice. For example, osteopetrosis, microphthalmus, and deficient natural killer cell a~t i v i v ' ,~~ are observed only in milmi mice, whereas anemia and deficiency of germ cells occur only in W mutant mice. Further studies will be necessary to understand the pleiotropic effects of mi mutation, and the differential phenotype of milmi mice and Wmutant mice.
In summary, the results presented here show that the attachment of milmi-CMC to fibroblasts is significantly impaired, and that milmi-CMC do not proliferate or differentiate in response to the stimuli presented either by fibroblasts or by c-kit ligand. It is likely that the impaired response and attachment of the cells may be due, at least in part, to low c-kit expression on their surface. Identification of the molecule encoded by the mi locus will be important in further understanding of the growth regulation and differentiation of mast cells.
